This new equipment expands the possibilities of identification and isolation of cellular and subcellular populations in a more precise way for use in biomedical research projects. IDIVAL already has a new CELL SEPARATOR (SORTER) in operation with greater functionalities, available both for IDIVAL researchers and external users. Its capacity to measure multiple cell parameters […]
These studies allow to have a better understanding of the seasonality of COVID-19 and to establish future vaccination strategies. Researchers from IDIVAL, Valdecilla Hospital and the University of Cantabria continue to analyze the influence of meteorological and geographical factors on the severity of COVID-19 in order to have a better understanding of the disease, its […]
The study, published in the prestigious scientific journal, opens the door to the development of new treatments Researchers from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Research Institute (IDIVAL) are participating in an international genetic study published in the journal Nature that reveals new therapeutic targets that could facilitate the […]
Spinocerebellar ataxia type 15 (SCA15), characterized by alterations in the strength, speed and dexterity of movements, is the disease on which the genetic study that could help in its diagnosis and treatment in the future has focused. Neurologists and geneticists from different centers have participated in the research, including the researcher José Berciano from the […]
The results of the latest study will allow progress to be made in the design of specific strategies for the management of cardiovascular risk according to sex. The ‘Immunopathology’ group of the Marqués de Valdecilla Health Research Institute (IDIVAL) coordinates a multicenter study with a dozen Spanish hospitals to investigate cardiovascular risk in patients with […]
Francisco Sánchez Madrid, member of IDIVAL’s External Council and Head of the Immunology Service of the Hospital Universitario de La Princesa has received the Robert Koch Award 2023. The immunologist and professor at Harvard University in Boston, Timothy Springer, has also been awarded this prize for their important joint research in Immunology. Both were pioneers […]
These donations are destined to study Alzheimer’s markers to detect people at high risk of suffering from this disease in the future. IDIVAL has received one more year the visit of Oscar Negrete and Fernando Cerro from the association ‘Unidos por un Reto’ to make a donation of 800€ that will be destined to Alzheimer’s […]
The results open the possibility of using 5 genes identified as markers that correlate with the severity of the disease in the brain. The `Neurodegenerative Diseases´ group of the Marqués de Valdecilla Health Research Institute (IDIVAL) led by Dr. Jon Infante Ceberio has participated in a european multicenter study with the aim of identifying genes […]
The research team from IDIVAL, HUMV and Sierrallana Hospital indicates that the results could help to prescribe the appropriate treatment and prevent complications. Identifying the causes of the decrease in the concentration of phosphorus in the blood was the main objective of the study carried out by the research team belonging to the Marqués de […]
This study sheds light on the processes that cause these ailments and possible future treatments. A research team from the Marqués de Valdecilla Health Research Institute (IDIVAL) and the Marqués de Valdecilla University Hospital (HUMV) has demonstrated the involvement of a molecule, a peptide known as CGRP, in COVID-19 infection, specifically in headache and diarrhoea, […]
